SLIDE 1
Page 1 of 3
Kingston Clinical Commissioning Group Governing Body Meeting in Public Date Tuesday, 08 January 2019 Document Title Dementia Deep Dive Lead Director
(Name and Role)
Julia Travers Director of Commissioning Clinical Sponsor
(Name and Role)
Dr Phil Moore Chair (Clinical) Author(s)
(Name and Role)
Brian Roberts, Performance and Information Lead Rachel Rowan, Mental Health Commissioner Dr Nerida Burnie, Dementia Lead and Kingston GP Agenda Item No. 2.1 Attachment No. C Purpose
(Tick as Required)
Approve Discuss Note Executive Summary CCGs are expected to encourage timely diagnosis of patients with dementia. To this end, the dementia diagnosis standard was introduced, and is monitored by NHS
- England. The measure calculates the dementia diagnosis rate by using the number of
people aged 65 and over with a diagnosis of dementia recorded within GP practice systems, over the estimated number of people aged 65 and over expected to have dementia in the population. Background: At present, the diagnosis rate in Kingston is 62.2% against an expected rate of 66.7% (equates to 80 people short of the expected rate). There have been several actions carried out by the CCG in support of GPs to increase the number and rate of people diagnosed with dementia, with other actions still being currently carried out. Further information will be covered in the presentation to the governing body meeting. Purpose: To inform the Kingston CCG Governing Body of the performance of the dementia standard against the targeted level. Reason for Committee Review: To make the Kingston CCG Governing Body aware of the actions that have been carried out and the ongoing actions that are still being currently carried out. Key Issues:
- 1. At present, the diagnosis rate in Kingston is 62.2%, 80 people short of the